Effects of the Angiotensin‐Receptor Neprilysin Inhibitor on Cardiac Reverse Remodeling: Meta‐Analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of the Angiotensin‐Receptor Neprilysin Inhibitor on Cardiac Reverse Remodeling: Meta‐Analysis
Authors
Keywords
-
Journal
Journal of the American Heart Association
Volume 8, Issue 13, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2019-06-26
DOI
10.1161/jaha.119.012272
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation: The PRIME Study
- (2019) Duk-Hyun Kang et al. CIRCULATION
- The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction
- (2018) Pieter Martens et al. Cardiovascular Therapeutics
- P787Angiotensin-neprilysin inhibition further reverses cardiac remodeling as compared to angiotensin inhibition in reduced heart failure patients
- (2018) C De Diego et al. EUROPACE
- Sacubitril/valsartan and short-term changes in the 6-minute walk test: A pilot study
- (2018) Paola Beltrán et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure
- (2018) Eric J. Velazquez et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study
- (2017) Roland E Schmieder et al. EUROPEAN HEART JOURNAL
- The Effects of LCZ696 in Patients With Hypertension Compared With Angiotensin Receptor Blockers
- (2017) Yang Zhao et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- LCZ696, a promising novel agent in treating hypertension (a meta-analysis of randomized controlled trials)
- (2017) Liwen Ye et al. Oncotarget
- Adverse Remodeling and Reverse Remodeling After Myocardial Infarction
- (2017) Ankeet S. Bhatt et al. Current Cardiology Reports
- Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction
- (2017) Scott D. Solomon et al. JACC-Heart Failure
- Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis
- (2016) Scott D. Solomon et al. EUROPEAN JOURNAL OF HEART FAILURE
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effects of renin–angiotensin–aldosterone system inhibitors on mortality, hospitalization, and diastolic function in patients with HFpEF
- (2015) Q. Zhang et al. HERZ
- The war against heart failure: the Lancet lecture
- (2015) Eugene Braunwald LANCET
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin Receptor Neprilysin Inhibition (ARNi) Attenuates Adverse Cardiac Remodelling In Vitro and In Vivo
- (2013) T. von Lueder et al. Heart Lung and Circulation
- Myocardial Motion and Deformation: What Does It Tell Us and How Does It Relate to Function?
- (2012) B. Bijnens et al. FETAL DIAGNOSIS AND THERAPY
- The past, present and future of renin–angiotensin aldosterone system inhibition
- (2012) Robert J. Mentz et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
- (2012) Scott D Solomon et al. LANCET
- Prevalence and Prognostic Significance of Left Ventricular Reverse Remodeling in Dilated Cardiomyopathy Receiving Tailored Medical Treatment
- (2011) Marco Merlo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Quantitative Evaluation of Drug or Device Effects on Ventricular Remodeling as Predictors of Therapeutic Effects on Mortality in Patients With Heart Failure and Reduced Ejection Fraction
- (2010) Daniel G. Kramer et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now